CIFAR (Canadian Institute for Advanced Research)
The Azrieli Foundation has donated $10 million to CIFAR, the largest philanthropic gift in the history of the organization.
Half of the gift will support the Azrieli Program in Brain, Mind & Consciousness, a cutting-edge research program that brings together leading researchers from around the world to explore the biological basis of human consciousness. The program draws on exceptional thinkers from across multiple disciplines, whose research will have important implications for understanding the brain and its disorders.
The other half will enable the launch of the CIFAR Azrieli Global Scholars program, which provides funding and support to help early career scholars build their research networks and develop essential skills to become leaders in global research.
Read news articles about this project:
The Azrieli Foundation, working with Brain Canada, supports translational research in the area of neurodevelopmental disorders with a special focus on Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). The goal of this multi-million dollar initiative is to develop new diagnostics, treatment and prevention strategies for neurodevelopmental disorders to reduce their economic and social burden on Canadians, and to improve the qualify of life for those affected by neurodevelopmental disorders and their families. This funding is supporting Canadian teams or the Canadian components of international teams doing innovative and collaborative research projects in the area of neurodevelopmental disorders. For more information about the teams that received funding, click here.
The Azrieli Institute will work in concert with the new Israel National Center for Brain Imaging and Stimulation, a government-funded entity to be led the Weizmann Institute and in partnership with the Technion and Sourasky Medical Center.
- Ask profound questions regarding the physiology, biochemistry, and functioning of the human brain
- Study major devastating pathologies associated with the brain
- Develop cutting-edge high-?field magnetic resonance methods and technologies for exploring the brain, and biological processes in vivo, in general
- Conduct multidisciplinary human brain research
- Create novel human brain therapies
Montreal’s Jewish General Hospital
The Board of the Azrieli Foundation was proud to join some of the staff at the Azrieli Medical and Surgical Intensive Care Unit to cut the ribbon, opening the renovated facility.
From left to right, 1st row: Dr. Emmanuel Moss, Cardiac Surgeon, Dr. Paul Warshawsky, Medical Director – Adult Critical Care, Danna Azrieli, Stephanie Azrieli, Myer Bick, President and CEO, JGH Foundation, Naomi Azrieli, Jacki Raboy Thaw, Nurse Coordinator – MSICU, Pina D’Orvé, Social Worker – MSICU, Martine Gagnon, Nursing Advisor – MSICU
From left to right, 2nd row: Susan Cameron, Nursing Advisor – MSICU, Dr. Lawrence Rudski, Chief, JGH Division of Cardiology
(Photo courtesy of MedPhoto, Jewish General Hospital)
The Dr. Mostafa Elhilali/David Azrieli Chair in Urological Sciences at McGill University, Montreal
The Chair is devoted to research in the field of urological surgery at McGill University Health Centre’s teaching hospitals.
The Azrieli Fellowship at Jewish General Hospital in Montreal
This fellowship provides opportunities for clinical, academic and research excellence as well as new approaches to medical diagnosis, treatment or research to young physicians and scientists of Israel in Canadian academic centres in Montreal affiliated with Jewish General Hospital.
Canada-Israel Health Research Program
In partnership with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR), and the Israel Science Foundation (ISF), the Azrieli Foundation is supporting cutting-edge biomedical research. This 7-year, CA$35M Canadian-Israeli effort draws on the unique scientific strengths of both countries and facilitates networking opportunities with peers from Africa, Asia, and Latin America. Approximately 30 projects will be funded over the program’s lifespan.
Azrieli Center for Stem Cells and Genetic Research at Hebrew University, Jerusalem, Israel
The Azrieli Center houses a stem cell repository for the purpose of researching and treating genetic disorders, along with imaging equipment and dedicated equipment for cell storage. Scientists at the Center conduct pioneering research towards a greater understanding of cellular and molecular mechanisms involved in genetic disorders such as Down syndrome, Prader-Willi syndrome and others, with a special focus on Fragile X syndrome, using models for these disorders. Researchers also focus on developing novel therapies to treat these diseases. The Center, led by Prof. Nissim Benvenisty, serves as a national and international hub for research into an array of genetic disorders and is a home to leading scientists, welcoming researchers from around the world.
Azrieli Institute for Systems Biology at Weizmann Institute of Science in Rehovot, Israel
The Azrieli Institute brings together scientists from across disciplines in research on the complex interactions of biological systems – a new form of study that combines the work of biologists, chemists, physicists, engineers, mathematicians and computer scientists. The Institute is poised to make tremendous insights a better understanding of antibiotic resistance, how new viruses arise, the immune system and why chemotherapy is sometimes ineffective.
The Azrieli Intensive Care Unit, Department of Cardiology at The Sheba Medical Center at Tel-Hashomer, Tel Aviv
The Sheba Medical Center at Tel Hashomer is the most comprehensive medical centre in the Middle East and a foremost global centre for medical education. The Azrieli Intensive Care Unit is housed in the newly designed Leviev Heart Center that integrates all Sheba’s diagnostic, therapeutic and preventive cardiovascular units.
The Azrieli Foundation does not consider applications for funding made directly to individual researchers. Grants are made through selected programs.